Journal of Advanced Biotechnology and Experimental Therapeutics
SJR0.230
BD
BDJournal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | — | — | 0.230 | Q3 | 33.5% | |
| 2024 | — | — | 0.240 | Q3 | 37.9% | |
| 2023 | — | — | 0.266 | Q3 | 45.0% | |
| 2022 | — | — | 0.205 | Q3 | 38.3% | |
| 2021 | — | — | 0.155 | Q4 | 31.4% | |
| 2020 | — | — | — | 0.0% | ||
| 2019 | — | — | — | 0.0% | ||
| 2018 | — | — | — | 0.0% | ||
Impact history
Annual SJR and Impact Factor trend.
SJR
Journal record
ISSN
2616-4760
country
BDcoverage
2018-2026